Article
The ATOM-Seq sequence capture panel can accurately predict microsatellite instability status in formalin-fixed tumour samples, alongside routine gene mutation testing.
Scientific reports - 19 Sept 2024
Srihar Kanishta, Gusnanto Arief, Richman Susan D, West Nicholas P, Galvin Leanne, Bottomley Daniel, Hemmings Gemma, Glover Amy, Natarajan Subaashini, Miller Rebecca, Arif Sameira, Rossington Hannah, Dunwell Thomas L, Dailey Simon C, Fontarum Gracielle, George Agnes, Wu Winnie, Quirke Phil, Wood Henry M
Abstract excerpt
Microsatellite instability (MSI) occurs across a number of cancers and is associated with different clinical characteristics when compared to microsatellite stable (MSS) cancers. As MSI cancers have different characteristics, routine MSI testing is now recommended for a number of cancer types including colorectal cancer (CRC). Using gene panels for sequencing of known cancer mutations is routinely performed to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
